GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Pacific Biosciences
Pacific Biosciences is a company developing long-read DNA sequencing technology. Its stock price is a bet that its HiFi technology will become the standard in genomic research. The chart reflects both technological breakthroughs and fierce competition with Illumina.
Share prices of companies in the market segment - Dna
Pacific Biosciences (PacBio) is a leader in the development of high-accuracy, long-read DNA sequencing systems, which are critical for scientific research and medicine. We've classified it in the "Dna" segment. The chart below reflects investor sentiment for the entire genomics technology sector, which is one of the most advanced in science.
Broad Market Index - GURU.Markets
Pacific Biosciences (PacBio) is a leader in long-read DNA sequencing technologies that enable a more complete genomic picture. As a component of the GURU.Markets index, the company is at the forefront of genetics. The chart below represents the entire market. See how PacBio shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
PACB - Daily change in the company's share price Pacific Biosciences
Daily fluctuations in Pacific Biosciences, a developer of DNA sequencing technologies, reflect the state of the genomics market. Change_co shows high sensitivity to scientific breakthroughs and equipment sales. This metric is key to biotech sector analysis on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Dna
The DNA sequencing sector, where Pacific Biosciences is a key player, is extremely volatile. This chart shows the average daily price movement for the entire life sciences industry. A comparison with PACB shares helps assess how its technological escalation makes the company riskier than the sector as a whole.
Daily change in the price of a broad market stock, index - GURU.Markets
Pacific Biosciences is a leader in long-read DNA sequencing technology. Its equipment is the foundation for breakthrough research. The chart below shows overall market volatility, which can be used to assess how the market perceives breakthrough biotech technologies.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Pacific Biosciences
For Pacific Biosciences (PacBio), the year-over-year performance is a story of competition in the DNA sequencing market. Its market capitalization growth over the past 12 months reflects the successful rollout of its new long-read genome sequencing platforms to research centers, a fundamental step in its battle for market share with giant Illumina.
Annual dynamics of market capitalization of the market segment - Dna
Pacific Biosciences of California, Inc. (PacBio) is a leader in long-read DNA sequencing technology, enabling the acquisition of more complete genomic information. This chart illustrates how its unique technology, competition, and reliance on R&D budgets influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pacific Biosciences, with its long-read DNA technology, is a bet on the future of genomics. Its stock price is highly volatile and depends on scientific breakthroughs and competition. The chart isn't about economics, but rather whether investors believe its approach will become the gold standard in research.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Pacific Biosciences
The performance of Pacific Biosciences, a DNA sequencing company, depends on its technology cycle. The monthly fluctuations on the chart reflect the demand for its long-read DNA systems from scientific labs, driven by their R&D budgets and competition from Illumina.
Monthly dynamics of market capitalization of the market segment - Dna
Pacific Biosciences of California (PacBio) is a biotechnology company pioneering high-fidelity long-read DNA sequencing (HiFi). The dynamics of its sector, shown in the graph, reflect scientific progress. Against this backdrop, one can appreciate how its unique technology, which enables a more complete view of the genome, is transforming scientific research and clinical diagnostics.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pacific Biosciences, a developer of DNA sequencing technologies, belongs to the innovative biotech sector. Its shares are driven by news about technological breakthroughs and competition. The chart shows how the company's performance is detached from the broader market and driven by sentiment in the genetic research industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Pacific Biosciences
Pacific Biosciences (PacBio) is a manufacturer of DNA sequencing equipment. Its weekly stock price is highly volatile, driven by the technological race in genomics, scientific breakthroughs, and its competition with the giant Illumina.
Weekly dynamics of market capitalization of the market segment - Dna
Pacific Biosciences, like the entire genomics sector, reacts weekly to general scientific breakthroughs and competitive news. The technological race in this segment impacts all players. This chart shows how PacBio aligns with the pulse of this innovative industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Pacific Biosciences is a pioneer in DNA sequencing technology. Shares of companies like this are driven not by employment reports, but by news of scientific breakthroughs. The chart clearly demonstrates how often the company's weekly performance diverges from the broader market.
Market capitalization of the company, segment and market as a whole
PACB - Market capitalization of the company Pacific Biosciences
The chart of Pacific Biosciences (PacBio) shows a bet on a revolution in DNA sequencing. Its market cap reflects investors' faith in long-read genome sequencing technology, which promises new breakthroughs in medicine and science. It's a highly volatile story about the future of genetics.
PACB - Share of the company's market capitalization Pacific Biosciences within the market segment - Dna
Pacific Biosciences (PacBio) is a pioneer and leader in the long-read DNA sequencing market. Its market share reflects its unique HiFi technology, which is essential for assembling complex genomes and understanding genetic variation.
Market capitalization of the market segment - Dna
Pacific Biosciences is a pioneer in long-read DNA sequencing. What is the scale of this revolution? The graph below shows the pulse of the entire DNA technology sector. Its dynamics reflect the scientific race to more fully understand the genome, opening new horizons in medicine and biology.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Pacific Biosciences (PacBio) chart is a visualization of the DNA sequencing revolution. The company's market cap, a pioneer in long-read genome sequencing technology, reflects investors' belief in its superiority in specific scientific and medical applications. This chart illustrates the technology race in genetics.
Book value capitalization of the company, segment and market as a whole
PACB - Book value capitalization of the company Pacific Biosciences
For Pacific Biosciences, a developer of DNA sequencing systems, book value is its tangible foundation: manufacturing facilities for assembling complex instruments, R&D laboratories, and reagent inventories. The chart below shows how the company has invested in its physical capital to revolutionize genomics.
PACB - Share of the company's book capitalization Pacific Biosciences within the market segment - Dna
Pacific Biosciences is a pioneer in long-range DNA sequencing. Its tangible assets are the high-tech production lines where its sophisticated sequencers and consumables are manufactured. The chart shows the company's control over this unique, science-intensive genetics production infrastructure.
Market segment balance sheet capitalization - Dna
Pacific Biosciences is a manufacturer of DNA sequencing systems. In a capital-intensive industry, its model is knowledge-intensive. Its asset portfolio is enormous. PacBio invests in R&D and manufacturing facilities to produce its unique and complex instruments.
Book value of all companies included in the broad market index - GURU.Markets
Pacific Biosciences' core assets are factories and laboratories where sophisticated long-read DNA sequencing equipment is built. The chart below shows how the company has grown its manufacturing and research capital to revolutionize genomics.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Pacific Biosciences
Pacific Biosciences' assets are sequencing factories. The market pays a huge premium for their unique long-read sequencing technology. The chart below shows how much faith in this technology exceeds the value of their assets.
Market to book capitalization ratio in a market segment - Dna
Pacific Biosciences develops cutting-edge DNA sequencing systems. Its value lies in its unique "long-read" technology. The chart shows how much its market capitalization, based on the potential of this technology, exceeds its current assets.
Market to book capitalization ratio for the market as a whole
Pacific Biosciences (PacBio) is a DNA sequencing equipment manufacturer known for its long-read technology. If this chart represents the average valuation, then PacBio is a company whose value lies in its unique technology. The market values its potential in scientific research and diagnostics, creating a high but volatile premium to its book value.
Debts of the company, segment and market as a whole
PACB - Company debts Pacific Biosciences
Pacific Biosciences (PacBio) is a pioneer in long-read DNA sequencing technology, which enables a more complete view of the genome. This chart shows how the company funds its expensive research and development. Raising capital is necessary to compete with the giant Illumina and advance its unique technology.
Market segment debts - Dna
Pacific Biosciences (PacBio) is a pioneer in long-read DNA sequencing technology, which enables the acquisition of more complete genomic information. This market requires significant investment in R&D. This chart shows how the company's debt policy reflects its capital needs to develop new, more powerful sequencers and compete with other technologies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Pacific Biosciences
Pacific Biosciences (PacBio) is a company developing cutting-edge DNA sequencing systems. This is a high-tech and rapidly growing field, requiring massive R&D investments. This chart shows how the company funds its innovations, helping to assess its financial sustainability in the race for genetic analysis technologies.
Market segment debt to market segment book capitalization - Dna
Pacific Biosciences (PacBio) is a developer of advanced DNA sequencing systems. This chart shows the debt burden in the biotech sector. It is an indicator of the company's ability to finance its expensive research and development in the highly competitive field of genomics, where technology is rapidly advancing.
Debt to book value of all companies in the market
Pacific Biosciences (PacBio) develops DNA sequencing systems. This is a cutting-edge and capital-intensive area of biotechnology. The company's growth depends on investments in R&D and marketing. This chart of total market debt demonstrates how favorable the investment climate is overall for funding companies making technological breakthroughs.
P/E of the company, segment and market as a whole
P/E - Pacific Biosciences
Pacific Biosciences (PacBio) is a pioneer in long-read DNA sequencing technology, which allows for a more complete and accurate view of the genome than short-read technologies. This chart reflects investor confidence in the superiority of this technology. Its performance is driven by sales of its sequencing systems and competition from market leader Illumina.
P/E of the market segment - Dna
Pacific Biosciences (PacBio) is a pioneer and leader in HiFi sequencing technology. This method allows for genome assembly with much greater accuracy than traditional methods. This chart shows the overall valuation of the DNA technology sector, reflecting the premium investors are willing to pay for cutting-edge genomics technologies.
P/E of the market as a whole
Pacific Biosciences (PacBio) is a company developing long-read DNA sequencing technologies, enabling the acquisition of more complete genetic information. Its valuation is a bet on a scientific breakthrough. It is not tied to the general economic cycles reflected in this chart, but depends on its ability to compete with market leader Illumina and its research budgets.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Pacific Biosciences
Pacific Biosciences (PacBio) is a company that develops and manufactures DNA sequencing systems renowned for their ability to read long sections of the genome (HiFi sequencing). This chart reflects expectations for a revolution in genomics. The company's valuation is a bet that its technology will become the standard for scientific research and clinical diagnostics.
%20P%2FE%20Pacific%20Biosciences&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Pacific-Biosciences&v=1772636747626 "Chart of the company's future (projected) P/E Pacific Biosciences")
Future (projected) P/E of the market segment - Dna
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology that enables a more complete view of the genome. This chart reflects investor confidence in its technological advantage. Comparing its forecasts with the sector reveals the premium the market is paying for its unique approach to genetics.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Dna&v=1772636747629 "Future (projected) P/E graph of the market segment - Dna")
Future (projected) P/E of the market as a whole
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology. This is a cutting-edge field of genetics. This overall risk appetite chart determines how willing investors are to fund companies with breakthrough but expensive technologies in the competitive field of life sciences.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772636747631 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Pacific Biosciences
Pacific Biosciences of California, Inc. (PacBio) is a company that develops and manufactures DNA sequencing systems renowned for their ability to read long sections of the genome. The company's profits depend on sales of these expensive systems and their consumables. This chart shows the path to profitability in the cutting-edge but competitive field of genomics.
Profit of companies in the market segment - Dna
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology that provides a more complete picture of the genome. This DNA technology profitability chart reflects how competition between different sequencing methods and the decreasing cost of genome analysis are driving scientific research and the development of personalized medicine.
Overall market profit
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems. Its long-read technology enables a more complete picture of the genome. The company is at the forefront of genomic research, and its growth depends on the implementation of its technology in scientific laboratories and clinics. PacBio is an indicator of progress in genetics and personalized medicine.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Pacific Biosciences
Pacific Biosciences (PacBio) develops DNA sequencing systems, specializing in long-read technology. This chart shows the expected growth of the genomic research market. Revenue depends on sales of its expensive instruments and consumables to research laboratories.
%20profit%20of%20the%20company%20Pacific%20Biosciences&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Pacific-Biosciences&v=1772636747653 "Graph of future (projected) profit of the company Pacific Biosciences")
Future (predicted) profit of companies in the market segment - Dna
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology. The forecast chart reflects revenue expectations for the life sciences sector. It allows one to assess the relevance of the company's unique technology in genomic research and personalized medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Dna&v=1772636747654 "Graph of future (predicted) profits of companies in a market segment - Dna")
Future (predicted) profit of the market as a whole
The trajectory on this graph shows expectations for a pioneer in DNA sequencing. Pacific Biosciences' profit forecast depends on sales of its long-read genome sequencing systems, which are used in scientific research. Competition in the genetic technology market is fierce, and growth depends on technological superiority.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772636747656 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Pacific Biosciences
Pacific Biosciences develops advanced DNA sequencing systems. This chart shows how investors value its revenue, which depends on sales of expensive instruments to scientific labs. The high multiple reflects confidence in the potential of its long-read DNA technology.
P/S market segment - Dna
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology. Revenue comes from sales of these expensive systems and consumables. This chart shows the average valuation in the life sciences sector, reflecting how the market views PacBio's technological advantage and its role in genomic research.
P/S of the market as a whole
Pacific Biosciences (PacBio) is a company that develops and manufactures DNA sequencing systems, specifically long-read technology, which enables a more complete view of the genome. This graph, showing PacBio's average revenue estimate, helps us understand the market premium for its cutting-edge technology in the rapidly growing field of genomics.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Pacific Biosciences
Pacific Biosciences (PacBio) is a manufacturer of DNA sequencing systems specializing in long-read technology, which enables the acquisition of more complete genetic information. This chart shows how investors estimate future revenue based on the implementation of its technology in research labs and clinics.
%20P%2FS%20Pacific%20Biosciences&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Pacific-Biosciences&v=1772636747694 "The graph of the company's future (projected) P/S Pacific Biosciences")
Future (projected) P/S of the market segment - Dna
Pacific Biosciences (PacBio) is a pioneer in long-read DNA sequencing technology. This chart compares market expectations for its future revenue with other companies in the DNA technology sector. This valuation reflects investor confidence in its HiFi technology and its application in genomic research.
%20P%2FS%20market%20segment%20graph%20-%20Dna&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Dna&v=1772636747707 "Future (projected) P/S market segment graph - Dna")
Future (projected) P/S of the market as a whole
Pacific Biosciences (PacBio) is a manufacturer of DNA sequencing systems specializing in long-read technology. Its equipment is used in scientific research to obtain a more complete picture of the genome. PacBio's revenue growth reflects advances in genetics and investment in biomedical sciences, a long-term trend.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772636747711 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Pacific Biosciences
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems renowned for their ability to read very long fragments of the genome. This chart shows revenue from sales of these expensive instruments and their consumables, reflecting the demand for cutting-edge genetic research.
Sales of companies in the market segment - Dna
Pacific Biosciences (PacBio) is a leader in long-read DNA sequencing technology, which provides a more complete and accurate picture of the genome. This technology is important for scientific research and medicine. This chart shows total sales in the sector, illustrating the growth of the genomic research market and the competition between different sequencing technologies.
Overall market sales
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology that provides a more complete picture of the genome. This graph, reflecting PacBio's investment in scientific research, is key. Growing budgets in genetics and personalized medicine are driving demand for its equipment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Pacific Biosciences
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology that enables a more complete view of the genome. This chart reflects analysts' expectations for growth in the genomic research market and the adoption of PacBio's technology in scientific and clinical laboratories.
%20sales%20of%20the%20company%20Pacific%20Biosciences&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Pacific-Biosciences&v=1772636747917 "Schedule of future (projected) sales of the company Pacific Biosciences")
Future (projected) sales of companies in the market segment - Dna
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems, specializing in long-read technology. This chart shows projected revenue for the entire life sciences sector. It reflects expected growth in the genomics market, which drives sales of PacBio's equipment and consumables.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Dna&v=1772636747944 "Schedule of future (projected) sales of companies in the market segment - Dna")
Future (projected) sales of the market as a whole
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems. Demand for its equipment comes from research institutes and biotechnology companies. This graph, reflecting the state of the economy, influences the volume of public and private research funding. Economic growth allows for greater investment in scientific research, which utilizes PacBio equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772636747960 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Pacific Biosciences
Pacific Biosciences is a manufacturer of long-read DNA sequencing systems. This chart reflects the company's business model for selling complex scientific equipment. Profitability depends on the company's ability to sell its expensive instruments and, more importantly, to secure a steady stream of revenue from the sale of consumables.
Market segment marginality - Dna
Pacific Biosciences (PacBio) is a pioneer in long-read DNA sequencing technologies that provide a more complete picture of the genome. This chart reflects the company's operational structure during the growth and competitive phase. It highlights its high R&D expenditures to maintain technological leadership in this important field.
Market marginality as a whole
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems. The company is a pioneer in long-read sequencing technology, which provides a more complete picture of genomes. The company's profitability depends on the adoption of its technology by research institutions. This graph of total market return highlights how PacBio operates at the forefront of science, where technological breakthroughs create markets.
Employees in the company, segment and market as a whole
Number of employees in the company Pacific Biosciences
Pacific Biosciences (PacBio) is a company developing DNA sequencing systems known for its long-read technology. This graph shows the team of scientists and engineers. The company's growth is directly related to the technological advancement in genomics and efforts to introduce its instruments to scientific and clinical laboratories worldwide.
Share of the company's employees Pacific Biosciences within the market segment - Dna
This indicator reflects the cutting-edge approach of Pacific Biosciences (PacBio). The company's biotechnology operations are focused on the development and sale of HiFi (long-read) DNA sequencing systems. This team of scientists and engineers offers technology that enables a more complete and accurate picture of the genome, essential for complex genetic research.
Number of employees in the market segment - Dna
Pacific Biosciences (PacBio) is a company that develops and manufactures DNA sequencing systems. Its long-read technology enables a more complete genetic picture. This graph illustrates how rapidly genomics is advancing, creating a demand for bioinformaticians, geneticists, and engineers who drive science forward.
Number of employees in the market as a whole
Pacific Biosciences of California, Inc. (PacBio) produces DNA sequencing systems. Its customers include research centers and pharmaceutical companies. This total employment chart reflects the economy, which funds science. A growing economy allows for greater investment in genomic research, which requires PacBio's equipment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Pacific Biosciences (PACB)
Pacific Biosciences (PacBio) is a pioneer in long-read DNA sequencing technology. This chart shows how the market values its unique technology. Its very high market capitalization per employee suggests that the company's primary value lies in its patents and research and development, not in its equipment production.
%20of%20the%20company%20Pacific%20Biosciences%20(PACB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Pacific-Biosciences-PACB&v=1772636748102 "Chart of market capitalization per employee (in thousands of dollars) of the company Pacific Biosciences (PACB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Dna
Pacific Biosciences (PacBio) develops cutting-edge DNA sequencing systems. In the Life Science Tools sector, high market capitalization per employee reflects the value of its unique technology. The chart shows the market premium placed on the company's ability to read long sections of the genome, opening new horizons in genetics.
%20by%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Dna&v=1772636748117 "Market capitalization per employee (in thousands of dollars) by market segment - Dna")
Market capitalization per employee (in thousands of dollars) for the overall market
Pacific Biosciences (PacBio) is a company that develops and manufactures DNA sequencing systems. This chart shows a high salary per employee, which is typical for the biotech sector. The company's value lies in its unique technology and patents, which play a key role in genomic research.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772636748133 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Pacific Biosciences (PACB)
Pacific Biosciences (PACB) is a manufacturer of long-read DNA sequencing systems. It is a competitor to Illumina in the genetics world. This graph (likely negative) shows the R&D burn rate. Profit per employee is a future goal; today, it represents the cost of creating a technology that is destined to become the new standard in genomics.
%20Chart%20Pacific%20Biosciences%20(PACB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Pacific-Biosciences-PACB&v=1772636748169 "Company Profit Per Employee (in thousands of dollars) Chart Pacific Biosciences (PACB)")
Profit per employee (in thousands of dollars) in the market segment - Dna
Pacific Biosciences (PacBio) is a manufacturer of DNA sequencing systems specializing in "long-read" (HiFi) technology. This technology enables high-precision genome imaging. This chart shows how effectively the company monetizes its expensive instruments and consumables. It serves as a benchmark for assessing PacBio's success in the scientific and clinical sequencing race.
%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Dna&v=1772636748186 "Chart of profit per employee (in thousands of dollars) in the market segment - Dna")
Profit per employee (in thousands of dollars) for the market as a whole
Pacific Biosciences (PACB) produces DNA sequencing systems (genome reading) known for their "long-read" technology. They are a high-tech R&D and medical equipment manufacturer. This graph (likely unprofitable) shows their race to the market. They are spending huge amounts of money on engineers to compete with Illumina. Their profit per employee will increase if labs start buying their expensive machines en masse.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772636748204 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Pacific Biosciences (PACB)
Pacific Biosciences (PacBio) develops and manufactures DNA sequencing systems. This chart shows productivity in the high-tech niche of genetic research. High revenue per employee is a result of selling expensive equipment and consumables to research laboratories.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Pacific-Biosciences-PACB&v=1772636748210 "Sales chart per company employee Pacific Biosciences (PACB)")
Sales per employee in the market segment - Dna
Pacific Biosciences (PacBio) is a company that develops and manufactures DNA sequencing systems (long-read sequencing). This chart shows the average revenue per employee in the segment. In the high-tech life sciences industry, this is a measure of the productivity of their R&D and commercial teams compared to competitors (like Illumina).
Sales per employee for the market as a whole
Pacific Biosciences (PACB) is a company that produces DNA sequencing equipment. Their HiFi technology allows for the reading of very long sections of the genome, which is important for science. It's a "razor and a blade" (equipment and consumables). This graph shows how their R&D and sales generate revenue in this highly specialized scientific niche.
Short shares by company, segment and market as a whole
Shares shorted by company Pacific Biosciences (PACB)
Pacific Biosciences (PACB) is a manufacturer of long-range DNA sequencing equipment. The bearish sentiment seen on this chart reflects fierce competition. Bears are betting that PACB is losing the technology race to giant Illumina, and that its equipment is too expensive and niche to achieve mass adoption.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Pacific-Biosciences-PACB&v=1772636748275 "Short Shares Chart for the Company Pacific Biosciences (PACB)")
Shares shorted by market segment - Dna
Pacific Biosciences (PacBio) is a manufacturer of HiFi DNA sequencing systems. This technology enables the reading of long sections of the genome. This chart shows the overall sentiment in the sector. It reflects investor concerns about intense competition (from Illumina and Oxford Nanopore) and the slow adoption of expensive sequencers.
Shares shorted by the overall market
Pacific Biosciences (PACB) is a manufacturer of DNA sequencing systems. This is a cutting-edge technology in the "genomic revolution," but the company is unprofitable and competes with giants. This chart is an indicator of risk appetite. When fear rises, investors are reluctant to fund expensive R&D wars and sell off shares of unprofitable "technologies of the future."
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Pacific Biosciences (PACB)
Pacific Biosciences is a manufacturer of long-read DNA sequencing equipment, a key technology in genomics. This is a bet on their technology against the giant Illumina. This chart measures when investors are overbuying the stock on expectations of a breakthrough or overselling it on fears of competition and slow adoption.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Pacific-Biosciences-PACB&v=1772636748316 "RSI 14 indicator chart for the company's stock Pacific Biosciences (PACB)")
RSI 14 Market Segment - Dna
Pacific Biosciences (PacBio) is a pioneer in HiFi sequencing. Their technology allows for reading very long sections of the genome, which is essential for complex research. This chart reflects the general sentiment in the genetic engineering sector and helps assess how overheated this futuristic segment of biotech is.
RSI 14 for the overall market
Pacific Biosciences (PACB) sells DNA sequencing equipment. This chart represents the pulse of its biotech customers. In the euphoria of biotech, they are generously funded and buying up PACB's expensive equipment. In a panic, R&D funding dries up, and hardware budgets are the first to be cut.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PACB (Pacific Biosciences)
Pacific Biosciences (PACB) is a manufacturer of long-read (HiFi) DNA sequencing equipment, which provides a more complete picture of the genome. This chart shows the average target price. It reflects analysts' belief in the superiority of this technology and its adoption in scientific and medical laboratories.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PACB-Pacific-Biosciences&v=1772636748340 "A chart showing analyst consensus forecasts for the expected stock price. PACB (Pacific Biosciences)")
The difference between the consensus estimate and the actual stock price PACB (Pacific Biosciences)
Pacific Biosciences (PACB) is a leader in third-generation DNA sequencing technology. Its HiFi (long-read) technology allows for more accurate genome imaging than competitors (like Illumina). This is an R&D bet. This chart shows the difference between the consensus estimate and the price. It reflects analysts' confidence in this breakthrough technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PACB-Pacific-Biosciences&v=1772636748353 "A chart showing the difference between the consensus forecast and the actual stock price. PACB (Pacific Biosciences)")
Analyst consensus forecast for stock prices by market segment - Dna
Pacific Biosciences (PacBio) is a key player in DNA sequencing, specializing in "long read" (HiFi) sequencing, which provides a more complete picture of the genome. This chart shows analysts' overall expectations for the entire DNA technology sector. It reflects whether experts believe R&D budgets for genetic research will grow.
Analysts' consensus forecast for the overall market share price
Pacific Biosciences (PacBio) is a manufacturer of DNA sequencing equipment. Their signature feature is "long-read" (HiFi) technology, which provides a more complete picture of the genome. They compete with Illumina. This chart shows the overall market sentiment. For PacBio, a "scientific" medtech company, it's important to understand how these expectations (R&D budgets) impact sales of their expensive equipment. (349)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Pacific Biosciences
Pacific Biosciences (PacBio) is the second-largest player in gene sequencing. Unlike Illumina (short-read), PacBio is the leader in long-read (HiFi), which provides a more complete picture of DNA. This chart is a barometer of their technology. It likely reflects the installation rate of their new, expensive machines (Revio) and (more importantly) the sales volume of their consumables (blades).
AKIMA Market Segment Index - Dna
Pacific Biosciences (PACB) is a leader in third-generation DNA sequencing; unlike Illumina, the company is a pioneer in long-read (HiFi) sequencing technology, which provides a more complete picture of the genome. This summary metric evaluates R&D. The graph shows the segment average. This benchmark: how does this breakthrough (HiFi) technology (PACB) differentiate it from its average medtech competitor?
The AKIM Index for the overall market
PacBio is a leader in long-read DNA (HiFi sequencing) technology, providing high-precision genomic data. This chart, reflecting the market average, provides context. It helps assess how this technology company, competing for research laboratory budgets, fits into the context of overall macroeconomic trends.
